RGD修飾的腺病毒介導(dǎo)LIF和IL-24雙基因共表達(dá)對人白血病細(xì)胞體內(nèi)外的抑癌增效作用
本文關(guān)鍵詞: RGD 腺病毒 LIF IL-24 白血病細(xì)胞 生長抑制 出處:《蘇州大學(xué)》2015年碩士論文 論文類型:學(xué)位論文
【摘要】:目的:構(gòu)建RGD修飾的LIF和/或IL-24單、雙基因腺病毒表達(dá)載體,研究其對人白血病MEG01細(xì)胞及裸鼠移植瘤體內(nèi)外的抑制作用及分子機(jī)制。方法:將本實(shí)驗(yàn)室構(gòu)建的LIF和/或IL-24重組轉(zhuǎn)移質(zhì)粒與RGD修飾的腺病毒骨架質(zhì)粒pAd(RGD)同源重組,經(jīng)QBI-293A細(xì)胞包裝獲得RGD修飾的Ad.RGD-LIF、Ad.RGD-IL24和Ad.RGD-LIF-IL24重組腺病毒載體。在293A細(xì)胞中擴(kuò)增并檢測病毒的效價(jià)。感染白血病K562、MEG01細(xì)胞,熒光顯微鏡和流式細(xì)胞儀檢測經(jīng)RGD修飾后的腺病毒載體對白血病細(xì)胞的感染效率。體外實(shí)驗(yàn)分為Ad.RGD-LIF、Ad.RGD-IL24、Ad.RGD-LIF-IL24腺病毒載體組和PBS對照組、Ad.RGD空病毒載體組。各實(shí)驗(yàn)組感染MEG01細(xì)胞后,Western blot檢測目的基因LIF、IL-24的表達(dá),通過CCK-8法檢測LIF和/或IL-24基因表達(dá)對MEG01細(xì)胞增殖的影響,PE-AnexinV/7-AAD雙染后,經(jīng)流式細(xì)胞儀檢測攜帶LIF和/或IL-24基因的腺病毒對MEG01細(xì)胞凋亡的影響。PI染色,流式細(xì)胞儀檢測各實(shí)驗(yàn)組細(xì)胞周期的變化。Transwell法檢測LIF和/或IL-24基因表達(dá)對MEG01細(xì)胞侵襲能力的影響。Western blot檢測細(xì)胞凋亡相關(guān)蛋白Bcl-2、Bax、Bad、P53的表達(dá),Real-time PCR檢測細(xì)胞周期及侵襲相關(guān)基因P21、E2F1、MMP-2/9的表達(dá)。體內(nèi)實(shí)驗(yàn),建立人白血病MEG01細(xì)胞裸鼠移植瘤模型,實(shí)驗(yàn)組在瘤體內(nèi)注射腺病毒Ad.RGD-LIF、Ad.RGD-IL24、Ad.RGD-LIF-IL24進(jìn)行治療,對照組注射PBS和Ad.RGD空病毒,隔日一次,共注射5次。通過觀察并測量瘤體體積、重量,研究LIF和/或IL-24基因表達(dá)對裸鼠移植瘤的生長抑制作用。移植瘤取出后,石蠟包埋切片,免疫組化檢測相關(guān)因子Bcl-2、Bax、Caspase3、P53、E2F1的表達(dá)。結(jié)果:成功構(gòu)建RGD修飾的腺病毒載體Ad.RGD-LIF、Ad.RGD-IL24和Ad.RGD-LIF-IL24。經(jīng)RGD修飾后,對白血病細(xì)胞MEG01的感染效率從30%提升到90%,K562細(xì)胞的感染效率從15%提升到50%左右。Western blot證實(shí)了腺病毒載體攜帶LIF和/或IL-24基因能夠在MEG01細(xì)胞中成功表達(dá),體外實(shí)驗(yàn)結(jié)果表明:與PBS組和空病毒組相比,Ad.RGD-LIF、Ad.RGD-IL24和Ad.RGD-LIF-IL24實(shí)驗(yàn)處理組均能夠明顯抑制MEG01細(xì)胞的增殖和誘導(dǎo)細(xì)胞凋亡,且Ad.RGD-LIF-IL24雙基因共表達(dá)組對細(xì)胞抑制作用更顯著;周期結(jié)果顯示,各實(shí)驗(yàn)組均能產(chǎn)生G2/M期阻滯作用;侵襲實(shí)驗(yàn)結(jié)果表明LIF和/或IL-24單、雙基因表達(dá)均能夠抑制MEG01細(xì)胞的侵襲轉(zhuǎn)移,且雙基因共表達(dá)的抑制作用更顯著。體內(nèi)實(shí)驗(yàn),成功建立裸鼠人白血病MEG01細(xì)胞移植瘤模型,瘤體內(nèi)注射攜帶目的基因LIF和/或IL-24的腺病毒治療后,移植瘤的生長受到明顯的抑制,且雙基因共表達(dá)組抑瘤作用更顯著。分子機(jī)制結(jié)果表明:Ad.RGD-LIF-IL24雙基因共表達(dá)能夠明顯上調(diào)Bax、P53、Caspase3、P21和下調(diào)Bcl-xl、Bcl-2、E2F1、MMP-2/9等細(xì)胞凋亡、周期及侵襲相關(guān)基因的表達(dá),且其效應(yīng)較Ad.RGD-LIF或Ad.RGD-IL24單基因組更為顯著。結(jié)論:1、成功構(gòu)建RGD修飾的腺病毒載體Ad.RGD-LIF、Ad.RGD-IL24、Ad.RGD-LIF-IL24。RGD修飾后,能夠顯著提升腺病毒載體對MEG01和K562細(xì)胞的感染效率。2、腺病毒載體攜帶LIF和/或IL-24單/雙基因表達(dá)在體外、體內(nèi)均能夠顯著抑制白血病MEG01細(xì)胞的生長和誘導(dǎo)細(xì)胞發(fā)生凋亡,且Ad.RGD-LIF-IL24雙基因共表達(dá)組具有抑癌增效作用。3、腺病毒載體攜帶LIF和/或IL-24單/雙基因在MEG01細(xì)胞中表達(dá)均能明顯上調(diào)Bax、P53、P21和下調(diào)Bcl-2、E2F1等凋亡和周期相關(guān)因子的表達(dá),從而誘導(dǎo)細(xì)胞凋亡并產(chǎn)生G2/M期阻滯;下調(diào)MMP-2/9的表達(dá)從而抑制MEG01細(xì)胞的侵襲;且Ad.RGD-LIF-IL24雙基因共表達(dá)組對凋亡、周期相關(guān)基因的調(diào)控作用更顯著,這可能是雙基因共表達(dá)發(fā)揮抑瘤增效作用的重要分子機(jī)制。
[Abstract]:Objective: to construct the RGD modified LIF and / or IL-24 single and double gene adenovirus expression vector of human leukemia MEG01 cells and xenografts in vivo inhibitory effect and molecular mechanism. Methods: the laboratory construction of adenovirus LIF and / or IL-24 recombinant transfer plasmid and RGD modified plasmid pAd (RGD) by homologous recombination, QBI-293A packaging cell RGD modified Ad.RGD-LIF, Ad.RGD-IL24 and Ad.RGD-LIF-IL24. The titer of recombinant adenovirus vector in 293A cells to amplify and detect the virus infection. Leukemia K562, MEG01 cell, fluorescence microscopy and flow cytometry. The infection efficiency of adenovirus vector RGD modified on leukemia cells in vitro experiments were divided into Ad.RGD-LIF, Ad.RGD-IL24, Ad.RGD-LIF-IL24 adenovirus vector group and PBS control group, Ad.RGD empty vector group. The experimental group MEG01 cells infected with Western blot detection LIF gene, the expression of IL-24 expression on the proliferation of MEG01 cell by detecting gene LIF and / or IL-24 CCK-8 method, PE-AnexinV/7-AAD staining, flow cytometry analysis with LIF and / or IL-24 gene of adenovirus.PI on apoptosis in MEG01 staining,.Transwell method was used to detect LIF gene changes and / or flow cytometry was used to detect IL-24 of each experimental group. Cell cycle detection of apoptosis related protein Bcl-2.Western blot, effects on the invasion ability of MEG01 cells to Bax, Bad, P53 expression, Real-time PCR detection of cell cycle and invasion related genes P21, E2F1, MMP-2/9 expression. In vivo, the establishment of the nude mouse model of leukemia MEG01 cells in the experimental group, intratumoral injection of adenovirus Ad.RGD-LIF, Ad.RGD-IL24, Ad.RGD-LIF-IL24 treatment, control group were injected with PBS and Ad.RGD virus, once every other day, a total of 5 injections. Through observation and measurement The tumor volume, weight, LIF and / or IL-24 expression inhibits tumor growth in nude mice. Tumor removed, paraffin section, immunohistochemical detection of factor Bcl-2, Bax, Caspase3, P53, E2F1. Results: the expression of adenovirus vector Ad.RGD-LIF was successfully constructed by RGD modified Ad.RGD-IL24. And Ad.RGD-LIF-IL24. modified by RGD infection efficiency on leukemia MEG01 cells increased from 30% to 90%, the infection efficiency of K562 cells increased from 15% to 50%.Western blot confirmed the adenovirus vector carrying LIF and / or IL-24 gene can be successfully expressed in MEG01 cells in vitro, the experimental results show that compared with the PBS group, and the empty virus group Ad.RGD-LIF, Ad.RGD-IL24 and Ad.RGD-LIF-IL24 treatments could significantly inhibit the proliferation of MEG01 cells and induce cell apoptosis, and Ad.RGD-LIF-IL24 genes were more inhibitory effect on cells The cycle; results show that all the experimental groups can produce G2/M phase arrest; invasion experiments show that LIF and / or IL-24 single and double gene expression were able to inhibit MEG01 cell invasion and metastasis, the more significant inhibition and double gene co expression. In vivo, successfully established in nude mice of human leukemia MEG01 cells model, intratumoral injection of adenovirus carrying LIF gene and / or IL-24 after transplantation tumor growth was inhibited, and the double gene co expression inhibition effect was more significant. The results show that the molecular mechanism of co expression of Ad.RGD-LIF-IL24 gene increased the expression of Bax, P53, Caspase3, P21 and down-regulation of Bcl-xl. Bcl-2, E2F1, MMP-2/9, apoptosis, cycle and expression of invasion related genes, and its effect is Ad.RGD-LIF or Ad.RGD-IL24 single genome is more significant. Conclusion: 1, adenovirus vector Ad.RGD-LIF was successfully constructed by RGD modified Ad.R. GD-IL24, Ad.RGD-LIF-IL24.RGD modification can significantly improve the infection efficiency of adenovirus vector.2 of MEG01 and K562 cells, LIF and / or IL-24 single / double gene expression in vitro and in vivo adenovirus, can inhibit leukemia MEG01 cell growth and induce cell apoptosis, and Ad.RGD-LIF-IL24 double gene co expression group with tumor effect of synergism of.3 cancer, adenovirus vector carrying LIF and / or IL-24 single / double gene expression in MEG01 cells was significantly up-regulated the expression of Bax, P53, P21 and down-regulation of Bcl-2 expression of E2F1, apoptosis and cycle related factors, from induced apoptosis and G2/M phase arrest; downregulation of MMP-2/9 inhibits MEG01 cell invasion; and Ad.RGD-LIF-IL24 double gene co expression group more significant role on the apoptosis, cycle related genes, which may be the co expression of tumor suppressor molecules play an important synergistic effect Mechanism.
【學(xué)位授予單位】:蘇州大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2015
【分類號】:R733.7;R450
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 哈小琴;王鯤;張玉;鄧芝云;董菊子;趙勇;彭俊華;;雙基因重組腺病毒表達(dá)載體pAdxsi-GFP-HIF-KGF的構(gòu)建及表達(dá)[J];西北國防醫(yī)學(xué)雜志;2013年06期
2 馬小松;王英振;王昌耀;劉金釗;;雙基因真核表達(dá)載體pIRES-BMP2-TGFβ3的構(gòu)建與鑒定(英文)[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2011年09期
3 左雨娜;焦德敏;于慧慧;張鑄業(yè);李宙陽;袁軍;劉愛和;王彥刈;;一種簡單的慢病毒載體介導(dǎo)的同時(shí)沉默雙基因的方法[J];中國現(xiàn)代醫(yī)學(xué)雜志;2010年03期
4 魏慶信;陳實(shí);魏雁;鄭新民;李莉;喬憲風(fēng);劉西梅;周荊榮;田永祥;;轉(zhuǎn)hMCP/hCD_(59)雙基因小鼠的構(gòu)建、傳代及功能測試[J];實(shí)驗(yàn)動(dòng)物與比較醫(yī)學(xué);2007年01期
5 邱紅;朱月蓉;邢繼成;江淑芳;蘇長青;曹祥榮;方琳;;攜帶人白細(xì)胞介素10和肝細(xì)胞生長因子雙基因的重組腺病毒載體構(gòu)建與鑒定[J];江蘇大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2010年01期
6 李莉,鄭新民,魏慶信,魏雁;轉(zhuǎn)人MCP和CD_(59)雙基因小鼠的制備[J];華中農(nóng)業(yè)大學(xué)學(xué)報(bào);2003年05期
7 賀偉峰,吳軍,易紹萱,羅高興,陳希煒,鄭峻松,馬兵,雷曉;人CTLA4Ig和EGFP雙基因共表達(dá)逆轉(zhuǎn)錄病毒載體構(gòu)建及鑒定[J];第三軍醫(yī)大學(xué)學(xué)報(bào);2002年07期
8 李亞歐;陳平;李志勇;文艷君;;HBx和mIL-12雙基因重組腺病毒的構(gòu)建[J];四川大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2010年06期
9 汪保燦,李定國,陳穎偉,孫超,孫巧玲,宗春華;smad7和uPA雙基因共表達(dá)重組腺病毒載體的構(gòu)建和鑒定[J];胃腸病學(xué)和肝病學(xué)雜志;2005年05期
10 張尚弟;哈小琴;楊志華;李兵;鄧芝云;姜東紅;張俊;王劍鋒;;攜帶IL-2和NK4雙基因真核共表達(dá)載體的減毒沙門菌株的構(gòu)建[J];解放軍醫(yī)藥雜志;2014年07期
相關(guān)會(huì)議論文 前6條
1 盛偉華;謝宇鋒;繆競誠;顧范博;朱曄涵;陳華昕;杜賢榮;楊吉成;;Ad-ING4-IRES-IL-24雙基因共表達(dá)載體構(gòu)建及表達(dá)[A];2010’全國腫瘤分子標(biāo)志及應(yīng)用學(xué)術(shù)研討會(huì)暨第五屆中國中青年腫瘤專家論壇論文匯編[C];2010年
2 謝宇鋒;盛偉華;繆競誠;顧范博;楊吉成;;Ad-ING4-PolyA-Promoter-IL-24雙基因共表達(dá)載體構(gòu)建及表達(dá)[A];2010’全國腫瘤分子標(biāo)志及應(yīng)用學(xué)術(shù)研討會(huì)暨第五屆中國中青年腫瘤專家論壇論文匯編[C];2010年
3 劉桂林;王志宇;衛(wèi)吉蕓;張珊珊;;原核雙基因共表達(dá)載體的構(gòu)建策略[A];全國動(dòng)物生理生化第十二次學(xué)術(shù)交流會(huì)論文摘要匯編[C];2012年
4 李莉;鄭新民;魏慶信;魏雁;;建立轉(zhuǎn)人MCP和CD_(59)雙基因小鼠的研究[A];中國實(shí)驗(yàn)動(dòng)物學(xué)會(huì)第六屆學(xué)術(shù)年會(huì)論文集[C];2004年
5 魏慶信;魏雁;鄭新民;李莉;喬憲風(fēng);劉西梅;周荊榮;田永祥;;轉(zhuǎn)人MCP和CD59雙基因小鼠的構(gòu)建及傳代研究[A];中國生物工程學(xué)會(huì)第四次會(huì)員代表大會(huì)暨學(xué)術(shù)討論會(huì)論文摘要集[C];2005年
6 李慶章;張莉;關(guān)宏斌;;重組山羊FSH雙基因真核表達(dá)載體的構(gòu)建[A];動(dòng)物生理生化學(xué)分會(huì)第八次學(xué)術(shù)會(huì)議暨全國反芻動(dòng)物營養(yǎng)生理生化第三次學(xué)術(shù)研討會(huì)論文摘要匯編[C];2004年
相關(guān)重要報(bào)紙文章 前1條
1 徐瑞哲;雙基因調(diào)控:干細(xì)胞“保量才保質(zhì)”[N];解放日報(bào);2007年
相關(guān)碩士學(xué)位論文 前7條
1 翟紅紅;利用AhCMO、AhBADH和AtNEK6基因提高植物耐旱、耐鹽性的研究[D];中國農(nóng)業(yè)科學(xué)院;2015年
2 李帥;RGD修飾的腺病毒介導(dǎo)LIF和IL-24雙基因共表達(dá)對人白血病細(xì)胞體內(nèi)外的抑癌增效作用[D];蘇州大學(xué);2015年
3 肖紅衛(wèi);精子介導(dǎo)轉(zhuǎn)CD59和MCP雙基因小鼠和豬的研究[D];西北農(nóng)林科技大學(xué);2006年
4 馬小松;BMP2和TGFβ3雙基因真核表達(dá)載體的構(gòu)建與鑒定[D];青島大學(xué);2011年
5 麻彩麗;柞蠶絲素作為VEGF165-Ang-1雙基因共表達(dá)質(zhì)粒傳遞載體的研究[D];蘇州大學(xué);2014年
6 左珊珊;裂殖弧菌△4去飽和酶與鹽生巴夫藻△5延長酶雙基因共轉(zhuǎn)促進(jìn)EPA向DHA轉(zhuǎn)化的研究[D];陜西師范大學(xué);2012年
7 周寅;基于雙基因載體系統(tǒng)的擬南芥維生素C合成代謝調(diào)控研究[D];復(fù)旦大學(xué);2010年
,本文編號:1442687
本文鏈接:http://sikaile.net/yixuelunwen/zlx/1442687.html